MIPS - Quality Measures -

Category	QUALITY
Description	Proportion of female patients (aged 18 years and older) with AJCC stage I (T1c) - III, human epidermal growth factor receptor 2 (HER2) positive breast cancer receiving adjuvant chemotherapy who are also receiving trastuzumab
eMeasure ID
First Performance Year	2017
Last Performance Year
Metric Type	Single Performance Rate
National Quality Strategy Domain	ECR
Measure Type	Process
eMeasure UUID
NQF eMeasure ID
NQF ID	1858
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward	American Society of Clinical Oncology
Submission Methods	Registry
Eligibility Options
Performance Options
Is Risk Adjusted?
Vendor ID
Is Registry Measure?
Registry Measure Spec	https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_450_Registry.pdf
Web Interface Measure Spec
Claims Measure Spec